|
|
|
|
LEADER |
00000cam a22000002a 4500 |
001 |
ocm52253251 |
003 |
OCoLC |
005 |
20141204200320.0 |
008 |
070531s2003 sz a b i000 0 eng d |
010 |
|
|
|a 2003362254
|
035 |
|
|
|a (Sirsi) i9789241545990
|
040 |
|
|
|a PIT
|c PIT
|d VAM
|d DUV#
|
020 |
|
|
|a 9241545992
|
035 |
|
|
|a (OCoLC)52253251
|
082 |
0 |
0 |
|a 362.16
|2 22
|
084 |
|
|
|a 44.52
|2 bcl
|
090 |
|
|
|a RA644.5
|b A33 2003
|
245 |
0 |
0 |
|a Adherence to long-term therapies :
|b evidence for action /
|c [editado por Eduardo Sabaté].
|
260 |
|
|
|a Geneva :
|b World Health Organization,
|c 2003.
|
300 |
|
|
|a xv, 198 p. :
|b col. il. ;
|c 26 cm.
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Ch. I. Defining adherence -- Ch. II. The magnitude of the problem of poor adherence -- Ch. III. How does poor adherence affect policy makers and health managers? -- Ch. IV. Lessons learned -- Ch. V. Towards the solution -- Ch. VI. How can improved adherence be translated into health and economics benefits? -- Ch. VII. Asthma -- Ch. VIII. Cancer (palliative care) -- Ch. IX. Depression -- Ch. X. Diabetes -- Ch. XI. Epilepsy -- Ch. XII. HIV/AIDS -- Ch. XIII. Hypertension -- Ch. XIV. Tobacco smoking cessation -- Ch. XV. Tuberculosis -- Annex I. Behavioural mechanisms explaining adherence -- Annex II. Statements by stakeholders -- Annex III. Table of reported factors by condition and dimension -- Annex IV. Table of reported interventions by condition and dimension -- Annex V. Global adherence interdisciplinary network (GAIN).
|
650 |
|
0 |
|a Enfermedades crónicas
|x Tratamiento.
|
700 |
1 |
|
|a Sabaté, Eduardo.
|
710 |
2 |
|
|a World Health Organization.
|
596 |
|
|
|a 35
|
942 |
|
|
|c LIBRO
|
999 |
|
|
|c 206789
|d 206789
|